Guidant kickback case: Army cardiologist fined $12,700

Boston Scientific

A U.S. District Court hit military cardiologist Major Jason Davis with $12,700 in fines to repay gifts and payments he received from Boston Scientific Corp. (NYSE:BSX) Guidant Corp.

The judge ordered Davis to repay “every dinner, every bottle of wine and every other gratuity that you have ever received from Guidant” in announcing the sentence against him.

The same relationship cost Guidant $600,000 last year to settle claims that it provided illegal payments to Davis "so that he would use the company’s medical devices in cardiac procedures he performed and use his influence with other physicians practicing at Madigan Army Hospital so they would use the company’s devices as well," according to a U.S. Dept. of Justice press release.

“We resolved the matter in November 2010 for an amount not material to us," BSX’s February 2011 annual report reads.

Between April and October 2007 Davis accepted nearly $5,000 from Guidant. Other payments included a $2,000 speaking fee and nearly $5,400 in meals and other items from 2005 to 2007.

Davis began working at Madigan Army Medical Center in 2004 and became chief of cardiology in 2008. Between January 2006 and February 2009, Boston Scientific provided him with meals, payments and other gratuities, and he almost exclusively used Boston Scientific pacemakers and implantable defibrillators.

"There is no question but that Dr. Davis committed a criminal offense, and that he should have known better, but there is also no doubt that those who plied him with food, alcohol, money and other courtesies knew exactly what they were doing, and why they were doing it," prosecutors wrote in their sentencing memo.

Although such exchanges are common in the private sector, government personnel are strictly forbidden from accepting gifts or payments from above $20.

At least 15 device companies have paid $6.5 billion to settle accusations of marketing fraud or illegal kickbacks since 2008, but no doctors have faced consequences, according to a joint investigation by ProPublica and the Washington Post.

"In many of the cases, it appears that not even a cursory investigation was done to see whether the physicians had behaved inappropriately," according to the investigation.

Boston Scientific is still struggling with the Guidant deal, commonly referred to as one of the most misguided in history. Late last month the company agreed to pay $9.25 million to settle allegations that the med-tech goliath’s Guidant subsidiary overcharged federal health care programs for medical devices.

In 2009, a Dept. of Justice probe led to a $22 million fine for allegations of illegal kickbacks for illegal kickbacks paid to docs for participation in post-market surveys in 2003 and 2004 in a bid to boost pacemaker and defibrillator sales.

In sentencing Davis, presiding Magistrate Judge Creatura found that "no patient’s health was compromised," and he is scheduled to be deployed to Afghanistan.

"Our military needs all medical resources it can get in a time of war, and it is the desire of this court that you continue to serve our country," Creatura said. 

RSS From Medical Design & Outsourcing

  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]
  • TSO3 begins shipment of STERIZONE VP4 Sterilizers to U.S.
    TSO3, a developer in sterilization technology for medical devices in healthcare settings, announced that the company has received purchase orders for multiple devices from the U.S. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and TSO3. “Finally,” said R.M. Rumble, president and CEO of TSO3. “Our Vision is […]
  • Turkish medical company is seeking reseller and OEM partners in the U.S.
    UZUMCU Medical Equipment, one of Turkey’s first and largest manufacturers of medical devices, is seeking reseller and OEM partners in the U.S. The company has an array of FDA-certified OR tables, surgical lights, surgical suction units, electro devices and other medical equipment. “We want to bring our experience with distributors throughout Europe and the Middle […]
  • QImaging introduces new CCD cameras for microscopy with modern software to streamline image capture
    QImaging, a manufacturer of scientific cameras for life science and OEM applications, introduces a new series of Retiga CCD cameras, accompanied by QImaging’s new acquisition software to deliver high-performance tools for microscopy and imaging to researchers at an affordable price. The new QImaging Retiga R1, Retiga R3 and Retiga R6 cameras offer valuable technical features […]
  • Sigma-Aldrich announces a new certification to aid IVD customers
    Sigma-Aldrich, a life science and high technology company, announced the company has received ISO 13485 certification for expanded quality assurance capabilities at its Dekalb and Barton facilities located in St. Louis. The certification extends Sigma-Aldrich’s ability to manufacture and offer critical raw materials, such as enzymes, proteins and antibodies used in diagnostic assays, and supplies in vitro […]
  • Prescribing the right power supply: Important considerations for using batteries to power medical devices
    Sol Jacobs, VP and General Manager, Tadiran Batteries Medical technology is advancing rapidly, requiring increasingly sophisticated power management solutions, especially when then the device needs to be self-powered. Battery-powered medical devices encompass a wide range of applications, including surgical drills, power tools, automatic external defibrillators (AEDs), infusion pumps, bone growth stimulators and other wearable devices, […]
  • Qosina announces the launch of its e-commerce website
    Qosina is pleased to announce the launch of its e-commerce website, making it easier to purchase thousands of medical device components from stock inventory. Visitors coming to the new Qosina.com will discover a new look and feel and improvements with every click including: · Easy navigation: A new category structure that mirrors the print catalog […]
  • Athermal laser machining for medical implants is the topic of Norman Noble’s latest whitepaper
    Thermal lasers have achieved extraordinary results in microprecision manufacturing of medical implants and devices the past 20 years. Devices we take for granted today, such as vascular stents, could not be produced without the technology; however, there are still significant limitations on what medical implant and device manufactures can produce using thermal lasers. One major issue […]
  • Sealevel announces the SeaISO family of USB isolators
    Sealevel announces the SeaISO family of USB isolators with 4 kV of medical-grade optical isolation between the host computer and connected USB equipment. SeaISO USB isolators are UL Recognized, in accordance with EN60601-1 3rd Edition, and protect both the power and data lines of connected USB devices from harmful ground loops, damaging transients and surges […]
  • The 21st Century Cures Discussion document recently released to the public
    It has been reported that among the 10,000 known diseases, 7,000 of which are considered rare, there are treatments for only 500. According to Dr. Francis Collins, Director of the National Institutes of Health (NIH), it now takes “around 14 years and $2 billion or more” to develop a new drug and “more than 95% […]

Leave a Reply